BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND NF1, NFNS, 4763, ENSG00000196712, P21359 AND Prognosis
22 results:

  • 1. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
    Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea.
    Yun J; Song H; Kim SM; Kim S; Kwon SR; Lee YE; Jeong D; Park JH; Kwon S; Yun H; Lee DS
    Hum Genomics; 2023 Feb; 17(1):13. PubMed ID: 36814285
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
    Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
    Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia.
    Morales CE; Stieglitz E; Kogan SC; Loh ML; Braun BS
    Blood Adv; 2021 Sep; 5(18):3587-3591. PubMed ID: 34464969
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Analysis of Gene Mutation and Clinical Characteristics in 19 Children with Juvenile Myelomonocytic leukemia].
    Weng KZ; Zheng YZ; Zhuang SQ; Chen HY; LE SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1811-1818. PubMed ID: 33283703
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Homogeneously staining region (hsr) on chromosome 11 is highly specific for KMT2A amplification in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    Sakhdari A; Tang Z; Ok CY; Bueso-Ramos CE; Medeiros LJ; Huh YO
    Cancer Genet; 2019 Oct; 238():18-22. PubMed ID: 31425921
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. High resolution Chromosomal Microarray Analysis (CMA) enhances the genetic profile of pediatric B-cell Acute Lymphoblastic leukemia patients.
    Mitrakos A; Kattamis A; Katsibardi K; Papadhimitriou S; Kitsiou-Tzeli S; Kanavakis E; Tzetis M
    Leuk Res; 2019 Aug; 83():106177. PubMed ID: 31261022
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinical and genetic analyses of juvenile myelomonocytic leukemia].
    Zeng MH; He XL; Yang MH; Zheng MC; Wan WQ; Zou RY; Chen KK
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Apr; 21(4):365-369. PubMed ID: 31014430
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Complex karyotype AML displays G2/M signature and hypersensitivity to PLK1 inhibition.
    Moison C; Lavallée VP; Thiollier C; Lehnertz B; Boivin I; Mayotte N; Gareau Y; Fréchette M; Blouin-Chagnon V; Corneau S; Lavallée S; Lemieux S; Marinier A; Hébert J; Sauvageau G
    Blood Adv; 2019 Feb; 3(4):552-563. PubMed ID: 30782614
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.
    Peltonen S; Kallionpää RA; Rantanen M; Uusitalo E; Lähteenmäki PM; Pöyhönen M; Pitkäniemi J; Peltonen J
    Int J Cancer; 2019 Dec; 145(11):2926-2932. PubMed ID: 30724342
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Integrated molecular profiling of juvenile myelomonocytic leukemia.
    Murakami N; Okuno Y; Yoshida K; Shiraishi Y; Nagae G; Suzuki K; Narita A; Sakaguchi H; Kawashima N; Wang X; Xu Y; Chiba K; Tanaka H; Hama A; Sanada M; Ito M; Hirayama M; Watanabe A; Ueno T; Kojima S; Aburatani H; Mano H; Miyano S; Ogawa S; Takahashi Y; Muramatsu H
    Blood; 2018 Apr; 131(14):1576-1586. PubMed ID: 29437595
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The genomic landscape of juvenile myelomonocytic leukemia.
    Stieglitz E; Taylor-Weiner AN; Chang TY; Gelston LC; Wang YD; Mazor T; Esquivel E; Yu A; Seepo S; Olsen S; Rosenberg M; Archambeault SL; Abusin G; Beckman K; Brown PA; Briones M; Carcamo B; Cooper T; Dahl GV; Emanuel PD; Fluchel MN; Goyal RK; Hayashi RJ; Hitzler J; Hugge C; Liu YL; Messinger YH; Mahoney DH; Monteleone P; Nemecek ER; Roehrs PA; Schore RJ; Stine KC; Takemoto CM; Toretsky JA; Costello JF; Olshen AB; Stewart C; Li Y; Ma J; Gerbing RB; Alonzo TA; Getz G; Gruber T; Golub T; Stegmaier K; Loh ML
    Nat Genet; 2015 Nov; 47(11):1326-1333. PubMed ID: 26457647
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Management of Two Juvenile Myelomonocytic leukemia Patients According to Clinical and Genetic Features.
    Tüfekçi Ö; Ören H; Demir Yenigürbüz F; Gözmen S; Karapınar TH; İrken G
    Turk J Haematol; 2015 Jun; 32(2):175-9. PubMed ID: 26316488
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Juvenile myelomonocytic leukemias].
    Lachenaud J; Strullu M; Baruchel A; Cavé H
    Bull Cancer; 2014 Mar; 101(3):302-13. PubMed ID: 24691193
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.
    Sakaguchi H; Okuno Y; Muramatsu H; Yoshida K; Shiraishi Y; Takahashi M; Kon A; Sanada M; Chiba K; Tanaka H; Makishima H; Wang X; Xu Y; Doisaki S; Hama A; Nakanishi K; Takahashi Y; Yoshida N; Maciejewski JP; Miyano S; Ogawa S; Kojima S
    Nat Genet; 2013 Aug; 45(8):937-41. PubMed ID: 23832011
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Next-generation-sequencing-based risk stratification and identification of new genes involved in structural and sequence variations in near haploid lymphoblastic leukemia.
    Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Fischer U; Dugas M; Hu J; Borkhardt A
    Genes Chromosomes Cancer; 2013 Jun; 52(6):564-79. PubMed ID: 23508829
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice.
    Vassiliou GS; Cooper JL; Rad R; Li J; Rice S; Uren A; Rad L; Ellis P; Andrews R; Banerjee R; Grove C; Wang W; Liu P; Wright P; Arends M; Bradley A
    Nat Genet; 2011 May; 43(5):470-5. PubMed ID: 21441929
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.
    Okamoto R; Ogawa S; Nowak D; Kawamata N; Akagi T; Kato M; Sanada M; Weiss T; Haferlach C; Dugas M; Ruckert C; Haferlach T; Koeffler HP
    Haematologica; 2010 Sep; 95(9):1481-8. PubMed ID: 20435627
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia.
    Yoshida N; Yagasaki H; Xu Y; Matsuda K; Yoshimi A; Takahashi Y; Hama A; Nishio N; Muramatsu H; Watanabe N; Matsumoto K; Kato K; Ueyama J; Inada H; Goto H; Yabe M; Kudo K; Mimaya J; Kikuchi A; Manabe A; Koike K; Kojima S
    Pediatr Res; 2009 Mar; 65(3):334-40. PubMed ID: 19047918
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype.
    Mrózek K
    Semin Oncol; 2008 Aug; 35(4):365-77. PubMed ID: 18692687
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.